Oncology
At CliniSciences, we are driven by our mission to ensure that every patient gets the right treatment at the right time. That is why we are trusted by the world’s leading biopharmaceutical companies to advance their preclinical, translational and clinical research programs. With our extensive experience in the areas of oncology and immuno-oncology leverage the infinite possibilities of scientific innovation.
Our capabilities respond to the growing need for proof of concept investigations for innovative therapeutic approaches and drugs in oncology and immune-oncology. If the perfect model is not available, we can develop a custom one with you.
CliniSciences Services serves all therapy types, including small molecules, antibodies, antibody-drug-conjugates (ADCs), bispecifics, new biological entities (oligonucleotides,
peptides, proteins), cell therapies, radiotherapies, vaccines, viral vectors and microbial vectors. Browse specific service packages by therapeutic strategy.
Oncology CRO services spanning discovery, development, and commercialization
Deliver your oncology therapy at scale with a CRO built to streamline development for personalized medicines.
World-class teams and technologies, broad capabilities, and deep oncology expertise will support you from promising molecule to patient impact.
